Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 4, 2023 11:45 AM 2 min read

Medical Marijuana Giants Lambaste NY Gov. Hochul For Weed Rollout Mess, Seek Licenses To Sell Recreational Weed

by Maureen Meehan Benzinga Editor
Follow

Four major medical marijuana retailers in New York sent a letter to Gov. Kathy Hochul urging her to give them licenses to sell adult-use cannabis as court injunctions continue to block licensing activity in the state. The letter points to the thousands of illicit shops, especially in NYC, while only 23 state-licensed shops have been approved to open. 

What Happened

This past week, state Supreme Court Justice Kevin Bryant reversed his preliminary injunction that could have led to a substantial increase in operational cannabis licensing pending the outcome of a lawsuit filed by service-disabled veterans. The decision essentially blocks legal retail licensing in the Empire State, while illicit weed sales run rampant. 

Let Medical Marijuana Companies Start Selling Recreational Weed

The four companies are calling on Gov. Hochul and the Office of Cannabis Management (OCM) to allow already existing MMJ companies like themselves to sell adult-use marijuana as Maryland successfully did by creating a hybrid license structure that allowed existing MMJ companies to sell to recreational users. 

“The state’s ineptitude is endangering New Yorkers who wish to use cannabis safely and legally, while also hurting taxpayers,” said the  Aug. 31 letter obtained by the NY Post and signed by Matt Darin, CEO of Curaleaf Holdings, Inc. (OTCQX: CURLF), Ben Kovler of Green Thumb Industries (OTCQX: GTBIF), Denis Curran, CEO of Acreage Acreage Holdings (OTCQX: ACRHF) and Brett Novey, CEO of PharmaCann. 

“OCM has abused its authority under New York’s adult use law, played politics with the licensing process, and allowed thousands of unregulated, commercial scale sellers to flood the market with unregulated and unsafe cannabis products,” the strongly-worded letter continues. “Today, the State’s entire cannabis ecosystem is in dire need of a new direction.” 

The MMJ operators say that immediately issuing them licenses would more than double the number of adult-use marijuana dispensaries, while helping other cannabis sellers, including social equity applicants with past pot convictions. 

Lawsuits And More Lawsuits

The long-drawn-out conflict in New York stems from a provision under the state's program that allows for the first retail weed licenses to be given to people who were negatively affected by the war on drugs or their immediate families. While initially viewed as an honorable gesture, NY's cannabis authorities seemed to be taking forever to implement the program, which ultimately has led to a series of lawsuits.

The most recent and probably most impactful case that has tied up the licensing process in the courts was brought by four disabled veterans who argue that the state’s preference for social equity candidates should include individuals like themselves. 

Want to hear more about NY's beleaguered cannabis rollout and what might help it along? Join us at the upcoming Benzinga Cannabis Capital Conference in Chicago on September 27 and 28. All information is available on bzcannabis.com

 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisGovernmentNewsPenny StocksRegulationsPoliticsLegalMarketsGeneralBen KovlerMatt Darin
CURLF Logo
CURLFCuraleaf Holdings Inc
Not Available-%
Overview
GTBIF Logo
GTBIFGreen Thumb Industries Inc
$7.284.45%
CURLF Logo
CURLFCuraleaf Holdings Inc
Not Available-%
Overview
GTBIF Logo
GTBIFGreen Thumb Industries Inc
$7.284.45%
Comments
Loading...